Elgemtumab

A4DAB099 | Phase-I/II
ERBB3/HER3
G1 / None
MorphoSys Novartis Memorial Sloan-Kettering Cancer Center Novartis Oncology
Phase-I/II
Whole mAb
LJM-716 LIM716 NOV-6 NOV6
—
IMGT PubChem (252827373) PubChem (381127578) PubChem (404719829) PubChem (404772857) PubChem (472405967) PubChem (480403249) PubChem (481988112) Thera-SAbDab YAbS
Avg A4D Score
-0.6673
Score Range
-0.67
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB099_4p59_H_L 4p59 98% -0.6673 6.5 9.0 -0.4209 -0.696